95%
Chronic Conditions in Seniors
Nearly 95% of adults aged 60+ have at least one chronic condition, highlighting the need for advanced therapies like NK cells.
∞
Combatting Age-Related Issues
NK cell therapy helps reduce age-related markers like p16 and β-galactosidase, showing its effectiveness in cellular rejuvenation.
30s
Cellular Aging Starts
Cellular aging begins in your 30s, making early intervention with NK cell therapy crucial for long-term health.
80%
Improved Cellular Health
NK cell therapies demonstrate up to 80% improvement in reducing inflammation and enhancing immune function.
Immune Defenses Against Age-Related Diseases
Maintaining a healthy immune system is the key to longevity. The immune system is challenged daily with attacks from foreign pathogens, and while a healthy immune system creates a strong and complex defense, the immune system’s ability to fight declines with age. Your chance of developing some form of cancer skyrockets after the age of 40 – reaching nearly 50% by the age of 80. One key cell type that is responsible for age-associated diseases is called a senescent cell, or a cell that simply occupies space but no longer has a functional purpose. What if we can deter the chance of developing these age-associated conditions by using adoptive cell transfer?
Key Fighters Against Cancer and Aging
Natural Killer (NK) cells are one of our first lines of defense against cancer, viruses, and importantly, senescent cells. Up to 15% of our white blood cells are comprised of these NK cells, which act as immediate responders to boost the immune system. With more than 1,000 ongoing clinical trials using NK cells, these mighty cells have shown compelling promise in destroying cancer cells and possibly even curing cancer altogether.
Fight Against Cancer and Aging
Natural Killer (NK) cells are emerging as a powerful tool in combating not only cancer but also the effects of aging. Recent groundbreaking research, detailed in the publication “Autologous NK Cells Propagated and Activated Ex Vivo Decrease Senescence Markers in Human PBMCs”, highlights their potential to eliminate senescent cells. Activated NK cells have demonstrated the ability to target and remove age-affected immune cells, significantly reducing markers of senescence. This remarkable capability could lead to a strengthened immune system, reduced inflammation, and potential relief from age-associated diseases. NK cells represent a transformative approach to enhancing longevity and vitality.
Transforming Health and Longevity



These graphs represent the p16 concentrations (left) and the β-galactosidase signals (right) in patients before and after NK cell therapy. Higher levels of p16 are indicative of senescence, and senescent cells are the only cells that express β-galactosidase. Following NK cell therapy, both p16 concentration and β-galactosidase signals are significantly reduced. This data suggests that our Natural Killer cells can eliminate senescence.








Unlocking Youthful Immunity with Rehealth
Like the immune system, NK cells also age over time. However, Rehealth has developed a proprietary method of purifying and expanding NK cells in order to activate them to a younger state. Imagine using your own cells to maintain a healthy and youthful immune system.
Here at Rehealth, we offer NK cell therapies for age-associated diseases with your immune health in mine. If we can reduce senescence of the immune system, we believe your immune system will be much healthier and capable of combating diseases and other obstacles it battles daily.
- Ruggeri, L., Capanni, M., Urbani, E., Perruccio, K., Shlomchik, W. D., Tosti, A., … & Velardi, A. (2002). Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science, 295(5562), 2097-2100.
- Parihar, R., Rivas, C., Huynh, M., Omer, B., Lapteva, N., & Metelitsa, L. S. (2012). NK cells expressing a chimeric activating receptor eliminate MDSCs and rescue impaired CAR-T cell activity against solid tumors. Cancer immunology research, 1(4), 292-302.
- Lanier, L. L. (2008). Evolutionary struggles between NK cells and viruses. Nature reviews immunology, 8(4), 259-268.
- Biron, C. A., & Byron, K. S. (1981). In vitro and in vivo studies of cytokines involved in the regulation of natural killer cell activity. Advances in immunology, 30, 77-131.
- Vivier, E., Raulet, D. H., Moretta, A., Caligiuri, M. A., Zitvogel, L., Lanier, L. L., … & Ugolini, S. (2011). Innate or adaptive immunity? The example of natural killer cells. Science, 331(6013), 44-49.
- Lee, K. M., Kim, J. I., Stott, R., Soohoo, J., O’Farrell, A. M., & Yee, C. (2015). Anti-tumor cytotoxicity mediated by natural killer cells is enhanced by antibodies to CD137.
- Parihar, R., Rivas, C., Huynh, M., Omer, B., Lapteva, N., & Metelitsa, L. S. (2012). NK cells expressing a chimeric activating receptor eliminate MDSCs and rescue impaired CAR-T cell activity against solid tumors. Cancer immunology research, 1(4), 292-302.
- Lee, J. H., & Jeong, H. J. (2018). Anti-inflammatory effects of natural killer cells. Journal of clinical medicine, 7(9), 1-10.
- Schafer, M. J., Miller, J. D., LeBrasseur, N. K., & White, T. A. (2019). Cellular senescence: a key driver of aging and age-related disease. Science, 364(6449), eaaw0919.
- Krizhanovsky, V., Yon, M., Dickins, R. A., Hearn, S., Simon, J., Miething, C., … & Lowe, S. W. (2008). Senescence of activated stellate cells limits liver fibrosis. Cell, 134(4), 657-667.